Chemical Genetics: We use C. elegans as a model system to model a variety of diseases, including neurodegeneration, mood disorders, muscle excitability, and helminthic infection. We use these models in high-throughput screens for novel drug leads, collaborate with other labs to test our hits in more complex systems, and then return to C. elegans to better understand the mechanism of action of the bioactive small molecules.
Posdoctoral Fellow: Stanford University
Ph.D.: University of Toronto
B.Sc.: Dalhousie University
Fields of Interest:
- Molecular Medicine and Human Genetics
- Genetic Models of Development and Disease
Currently Accepting Graduate Students